Effects of α-MSH on ischemia/reperfusion injury in the rat sciatic nerve

Erhan Turkoglu1, Gökhan Serbes, Habibullah Dolgun

  • 1Ministry of Health Diskapi Yildirim Beyazit Research and Educational Hospital 1 Neurosurgery Clinic, 06610, Ankara, Turkey.

Abstract

Insights

Alpha-melanocyte stimulating hormone (α-MSH) pre-treatment protects peripheral nerves from ischemia/reperfusion (I/R) injury. This study shows α-MSH reduces oxidative stress and preserves nerve tissue integrity following I/R in a rat model.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Ischemia/reperfusion (I/R) induces oxidative stress and nerve damage.
  • Investigating the protective effects of alpha-melanocyte stimulating hormone (α-MSH) against sciatic nerve I/R injury.
  • Exploring the cytoprotective and antioxidant mechanisms of α-MSH.

Purpose of the Study:

  • To evaluate the efficacy of α-MSH in mitigating I/R-induced peripheral nerve damage.
  • To assess the impact of α-MSH on oxidative stress markers and nerve morphology post-ischemia.
  • To elucidate the protective role of α-MSH in a rat sciatic nerve I/R model.

Main Methods:

  • Utilized a rat model with 3-hour sciatic nerve ischemia induced by femoral vessel clamping.
  • Administered 75 μg/kg α-MSH subcutaneously prior to reperfusion in experimental groups.
  • Measured malondialdehyde (MDA) levels as an indicator of lipid peroxidation and assessed nerve tissue morphology and ultrastructure.

Main Results:

  • MDA levels, a marker of lipid peroxidation, increased on the first day of reperfusion but were reduced in α-MSH treated groups.
  • α-MSH pre-treatment significantly diminished myelin breakdown and improved axonal ultrastructural integrity.
  • Reperfusion injury onset was observed after the first hour of reperfusion.

Conclusions:

  • Pre-treatment with α-MSH effectively protects peripheral nerves against ischemia/reperfusion injury.
  • α-MSH demonstrates significant cytoprotective and antioxidant properties in the context of nerve I/R.
  • The findings support α-MSH as a potential therapeutic agent for nerve injury associated with I/R events.

Related Concept Videos